Related Experiment Video
Updated: Aug 12, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase
Steven Harper1, Barbara Pacini, Salvatore Avolio
1IRBM (Merck Research Laboratories Rome), Via Pontina km 30,600, 00040 Pomezia, Rome, Italy. Steven_Harper@merck.com
Abstract:
Allosteric inhibition of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase enzyme has recently emerged as a viable strategy toward blocking replication of viral RNA in cell-based systems. We report here a novel class of allosteric inhibitor of NS5B that shows potent affinity for the NS5B enzyme and effective inhibition of subgenomic HCV RNA replication in HUH-7 cells. Inhibitors from this class have promising characteristics for further development as anti-HCV agents.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

